DekaBank Deutsche Girozentrale’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Hold |
20,000
| – | – | ﹤0.01% | 1021 |
|
|
2025
Q1 | $365K | Hold |
20,000
| – | – | ﹤0.01% | 1014 |
|
|
2024
Q4 | $345K | Hold |
20,000
| – | – | ﹤0.01% | 1063 |
|
|
2024
Q3 | $364K | Hold |
20,000
| – | – | ﹤0.01% | 1071 |
|
|
2024
Q2 | $364K | Hold |
20,000
| – | – | ﹤0.01% | 1062 |
|
|
2024
Q1 | $364K | Hold |
20,000
| – | – | ﹤0.01% | 1058 |
|
|
2023
Q4 | $393K | Hold |
20,000
| – | – | ﹤0.01% | 1091 |
|
|
2023
Q3 | $361K | Hold |
20,000
| – | – | ﹤0.01% | 1089 |
|
|
2023
Q2 | $394K | Hold |
20,000
| – | – | ﹤0.01% | 1074 |
|
|
2023
Q1 | $349K | Hold |
20,000
| – | – | ﹤0.01% | 1088 |
|
|
2022
Q4 | $405K | Sell |
20,000
-23,000
| -53% | -$466K | ﹤0.01% | 1082 |
|
|
2022
Q3 | $1.11M | Hold |
43,000
| – | – | ﹤0.01% | 850 |
|
|
2022
Q2 | $1.05M | Hold |
43,000
| – | – | ﹤0.01% | 864 |
|
|
2022
Q1 | $1.44M | Buy |
43,000
+3,900
| +10% | +$130K | ﹤0.01% | 832 |
|
|
2021
Q4 | $1.65M | Buy |
39,100
+1,100
| +3% | +$46.4K | ﹤0.01% | 817 |
|
|
2021
Q3 | $1.31M | Buy |
+38,000
| New | +$1.31M | ﹤0.01% | 837 |
|